The Greater Cannabis Company, Inc. (GCAN)

OTCMKTS: GCAN · Delayed Price · USD
0.0015
0.0000 (0.00%)
May 27, 2022 4:00 PM - Market closed
Market Cap762,957
Revenue (ttm)25,260
Net Income (ttm)-635,259
Shares Out508.64M
EPS (ttm)0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,172,132
Open0.0015
Previous Close0.0015
Day's Range0.0012 - 0.0017
52-Week Range0.0011 - 0.0085
Beta1.13
Analystsn/a
Price Targetn/a
Earnings Daten/a

About GCAN

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.

IndustryDrug Manufacturers-Specialty & Generic
Employees1
Stock ExchangeOTCMKTS
Ticker SymbolGCAN
Full Company Profile

News

GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special

The 6 th Installment in the Award-winning Series by Dr. Sanjay Gupta will Air on Sunday, December 19 th at 9pm ET

5 months ago - GlobeNewsWire

GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor

Dr. Aran will be focused on furthering development of the therapeutic pipeline, advancing the clinical study program and supporting IP and regulatory strategies.

5 months ago - GlobeNewsWire

GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

BALTIMORE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid ther...

6 months ago - GlobeNewsWire

GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy

BALTIMORE, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTCQB: GCAN) a cannabis innovator specializing in the development of pharmaceutical and consumer ...

9 months ago - GlobeNewsWire

GCANRx Announces Collaboration with Renowned Cannabis Research Lab

BALTIMORE, March 16, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company ( OTCQB: GCAN ), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is ...

1 year ago - GlobeNewsWire

Greater Cannabis Company Announces Retirement of Remaining Convertible Debt

BALTIMORE, MD, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Greater Cannabis Company (GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products today...

1 year ago - GlobeNewsWire